newsfilter
← Latest News
GlobeNewswire·

Baudax Bio Reports First Quarter 2022 Financial Results and Business Highlights

ANJESO® Net Product Revenue Up 113% Compared to Same Period in Prior Year; Sixth Consecutive Quarter of Demand Growth First Cohort Dosed in Pediatric ANJESO Surgical Study Management to Host Investor Conference Call and Webcast Tomorrow at 8: